Neurocrine Biosciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -73.53. In total, the insiders bought 862.95K and sold 381.94K NBIX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-73.53
Buy 862.95K shares
Sell 381.94K shares
70% Buy Activity
Negligible or No Correlation
Sell Signal Medium Confidence
May 19, 2026

Analysis Breakdown:

  • Strongly supported by a very low Insider Power Score of -73.53.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 05, 2026
Sell
Common Stock
S-Sale
Sherwin Stephen A
Director
Director 7 883
Value: $1.29M
Jun 05, 2026
Sell
Common Stock
S-Sale
Sherwin Stephen A
Director
Director 5 829
Value: $970.9K
Jun 05, 2026
Sell
Common Stock
S-Sale
Sherwin Stephen A
Director
Director 1 843
Value: $308.4K
Jun 05, 2026
Buy
Non-Qualified Stock Option
M-Exempt
Sherwin Stephen A
Director
Director 10 000
Value: $797.9K
Jun 05, 2026
Sell
Common Stock
G-Gift
Onyia Jude
Chief Scientific Officer
Officer 2 441
Value: $0
Jun 05, 2026
Buy
Non-Qualified Stock Option
M-Exempt
Sherwin Stephen A
Director
Director 15 000
Value: $804.6K
Jun 05, 2026
Sell
Common Stock
S-Sale
Sherwin Stephen A
Director
Director 6 896
Value: $1.14M
Jun 05, 2026
Sell
Common Stock
S-Sale
Sherwin Stephen A
Director
Director 2 549
Value: $419.2K
Jun 05, 2026
Buy
Common Stock
M-Exempt
Sherwin Stephen A
Director
Director 15 000
Value: $804.6K
Jun 05, 2026
Buy
Common Stock
M-Exempt
Sherwin Stephen A
Director
Director 10 000
Value: $797.9K
Jun 04, 2026
Sell
Common Stock
S-Sale
Norwalk Leslie V
Director
Director 1 250
Value: $210.1K
Jun 02, 2026
Sell
Common Stock
S-Sale
Cooke Julie
Chief Human Resources Officer
Officer 5 466
Value: $849.7K
Jun 02, 2026
Buy
Common Stock
M-Exempt
Cooke Julie
Chief Human Resources Officer
Officer 24 965
Value: $2.03M
Jun 02, 2026
Sell
Common Stock
S-Sale
Cooke Julie
Chief Human Resources Officer
Officer 9 521
Value: $1.50M
Jun 02, 2026
Sell
Common Stock
S-Sale
Cooke Julie
Chief Human Resources Officer
Officer 4 216
Value: $660.9K
Jun 02, 2026
Buy
Common Stock
M-Exempt
Keswani Sanjay Chandru
Chief Medical Officer
Officer 3 212
Value: $497.3K
Jun 02, 2026
Buy
Restricted Stock Unit
M-Exempt
Keswani Sanjay Chandru
Chief Medical Officer
Officer 3 212
Value: $497.3K
Jun 02, 2026
Buy
Non-Qualified Stock Option
M-Exempt
Cooke Julie
Chief Human Resources Officer
Officer 24 965
Value: $2.03M
Jun 02, 2026
Sell
Common Stock
S-Sale
Cooke Julie
Chief Human Resources Officer
Officer 3 520
Value: $558.2K
Jun 02, 2026
Sell
Common Stock
S-Sale
Cooke Julie
Chief Human Resources Officer
Officer 14 214
Value: $2.20M
Jun 02, 2026
Sell
Common Stock
F-InKind
Keswani Sanjay Chandru
Chief Medical Officer
Officer 1 733
Value: $268.3K
Jun 01, 2026
Buy
Non-Qualified Stock Option
M-Exempt
Onyia Jude
Chief Scientific Officer
Officer 11 000
Value: $932.1K
Jun 01, 2026
Buy
Common Stock
M-Exempt
Onyia Jude
Chief Scientific Officer
Officer 11 000
Value: $932.1K
Jun 01, 2026
Sell
Common Stock
S-Sale
Onyia Jude
Chief Scientific Officer
Officer 11 000
Value: $1.76M
May 29, 2026
Sell
Common Stock
S-Sale
Delaet Ingrid
Chief Regulatory Officer
Officer 2 261
Value: $354.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT NEUROCRINE BIOSCIENCES
Neurocrine Biosciences
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products include ON...
GOLDEN STAR
Ticker Change Signal Date
JLL
$298.94
1.61% Jun 23
CBRE
$133.21
1.03% Jun 23
CAG
$13.43
2.72% Jun 23
TTEK
$28.04
1.43% Jun 23
NESR
$25.07
7.62% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE